SI
LUNG icon

Sofinnova Investments’s Pulmonx LUNG Stock Holding History

Sofinnova Investments’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-61,326
Closed -$416K – 79
2024
Q4 		$416K Sell
61,326
-987
-2% -$6.5K 0.03% 60
2024
Q3 		$517K Buy
62,313
+2,067
+3% +$15K 0.04% 60
2024
Q2 		$382K Buy
+60,246
New +$463K 0.02% 78

Other funds holding LUNG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sofinnova Investments's LUNG Position: Q1 2025 in Review

Sofinnova Investments sold out of Pulmonx (LUNG) in Q1 2025, closing a stake of 61,326 shares — an estimated $416K sold.

Sofinnova Investments first reported a position in LUNG in Q2 2024 and held it in 3 quarters. The position peaked at $517K in Q3 2024. 115 funds tracked by Wall St. Rank hold LUNG as of Q1 2025.

  • Sofinnova Investments reported no remaining Pulmonx position as of Q1 2025 after selling out during the quarter.
  • Sofinnova Investments sold 61,326 Pulmonx shares in Q1 2025, an estimated $416K.
  • Sofinnova Investments first reported a position in Pulmonx in Q2 2024 and held it in 3 quarters.
  • Sofinnova Investments's Pulmonx position peaked at $517K in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Pulmonx as of Q1 2025.

Based on Sofinnova Investments's 13F filing for Q1 2025, filed 15 May 2025.